A secreted form of P-cadherin is expressed in malignant melanoma

Experimental Cell Research

Volumn 305, Issue 2, 2005, Pages 418-426

  Bauer, R ^a   Hein, R ^b   Bosserhoff, A K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Invasion; Melanoma; P cadherin; Secretion; Translation

Indexed keywords

CADHERIN; CYTOPLASM PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; P CADHERIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL LINE; CELL MEMBRANE; CONTROLLED STUDY; EXON; GENOME ANALYSIS; GENOMICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRON; KERATINOCYTE; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; MOLECULAR INTERACTION; MOLECULE; MOUSE; MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SECRETION; RNA ANALYSIS; SEQUENCE ANALYSIS;

EID: 16244418364     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.01.024     Document Type: Article

References (41)

1. M.J. Wheelock, and K.R. Johnson Cadherins as modulators of cellular phenotype Annu. Rev. Cell Dev. Biol. 19 2003 207 235
2. E.C. McGary, D.C. Lev, and M. Bar-Eli Cellular adhesion pathways and metastatic potential of human melanoma Cancer Biol. Ther. 1 2002 459 465
3. T. Bogenrieder, and M. Herlyn Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma Crit. Rev. Oncol./Hematol. 44 2002 1 15
4. I. Poser, D. Dominguez, A.G. de Herreros, A. Varnai, R. Buettner, and A.K. Bosserhoff Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail J. Biol. Chem. 276 2001 24661 24666
5. G. Berx, K. Staes, J. van Hengel, F. Molemans, M.J. Bussemakers, A. van Bokhoven, and F. van Roy Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1) Genomics 26 1995 281 289
6. R. Silye, A.J. Karayiannakis, K.N. Syrigos, S. Poole, S. van Noorden, W. Batchelor, H. Regele, W. Sega, H. Boesmueller, T. Krausz, and M. Pignatelli E-cadherin/catenin complex in benign and malignant melanocytic lesions J. Pathol. 186 1998 350 355
7. D.S. Sanders, K. Blessing, G.A. Hassan, R. Bruton, J.R. Marsden, and J. Jankowski Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours Mol. Pathol. 52 1999 151 157
8. U.H. Frixen, J. Behrens, M. Sachs, G. Eberle, B. Voss, A. Warda, D. Lochner, and W. Birchmeier E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells J. Cell Biol. 113 1991 173 185
9. K. Vleminckx, L. Vakaet Jr., M. Mareel, W. Fiers, and F. van Roy Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell 66 1991 107 119
10. M. Watabe, A. Nagafuchi, S. Tsukita, and M. Takeichi Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line J. Cell Biol. 127 1994 247 256
11. K. Jacob, F. Wach, U. Holzapfel, R. Hein, E. Lengyel, R. Buettner, and A.K. Bosserhoff In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid Melanoma Res. 8 1998 211 219
12. E. Sprecher, R. Bergman, G. Richard, R. Lurie, S. Shalev, D. Petronius, A. Shalata, Y. Anbinder, R. Leibu, I. Perlman, N. Cohen, and R. Szargel Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin Nat. Genet. 29 2001 134 136
13. M.Y. Hsu, M.J. Wheelock, K.R. Johnson, and M. Herlyn Shifts in cadherin profiles between human normal melanocytes and melanomas J. Invest. Dermatol. Symp. Proc. 1 1996 188 194
14. P.C. Seline, D.A. Norris, T. Horikawa, M. Fujita, M.H. Middleton, and J.G. Morelli Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation J. Invest. Dermatol. 106 1996 1320 1324
15. A. Rattner, J. Chen, and J. Nathans Proteolytic shedding of the extracellular domain of photoreceptor cadherin. Implications for outer segment assembly J. Biol. Chem. 279 2004 42202 42210
16. N.E. Paradies, and G.B. Grunwald Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function J. Neurosci. Res. 36 1993 33 45
17. A. Lochter, S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells J. Cell Biol. 139 1997 1861 1872
18. P. Marambaud, J. Shioi, G. Serban, A. Georgakopoulos, S. Sarner, V. Nagy, L. Baki, P. Wen, S. Efthimiopoulos, Z. Shao, T. Wisniewski, and N.K. Robakis A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions EMBO J. 21 2002 1948 1956
19. T.C. Tolboom, A.L. Huidekoper, I.M. Kramer, E. Pieterman, R.E. Toes, and T.W. Huizinga Correlation between expression of CD44 splice variant v8-v9 and invasiveness of fibroblast-like synoviocytes in an in vitro system Clin. Exp. Rheumatol. 22 2004 158 164
20. G. Yang, H. Ge, A. Boucher, X. Yu, and C. Li Modulation of direct leptin signaling by soluble leptin receptor Mol. Endocrinol. 18 2004 1354 1362
21. B. Lainez, J.M. Fernandez-Real, X. Romero, E. Esplugues, J.D. Canete, W. Ricart, and P. Engel Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2 Int. Immunol. 16 2004 169 177
22. P. Blanco-Arias, C.A. Sargent, and N.A. Affara Protocadherin X (PCDHX) and Y (PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains Mamm. Genome 15 2004 41 52
23. C.M. Feltes, A. Kudo, O. Blaschuk, and S.W. Byers An alternatively spliced cadherin-11 enhances human breast cancer cell invasion Cancer Res. 62 2002 6688 6697
24. R. Kawano, N. Matsuo, H. Tanaka, M. Nasu, H. Yoshioka, and K. Shirabe Identification and characterization of a soluble cadherin-7 isoform produced by alternative splicing J. Biol. Chem. 277 2002 47679 47685
25. H.G. Morse, and G.E. Moore Cytogenetic homogeneity in eight independent sites in a case of malignant melanoma Cancer Genet. Cytogenet. 69 1993 108 112
26. I.J. Chalmers, H. Hofler, and M.J. Atkinson Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma Genomics 57 1999 160 163
27. S. Yu, M. Mangelsdorf, D. Hewett, L. Hobson, E. Baker, H.J. Eyre, N. Lapsys, D. Le Paslier, N.A. Doggett, G.R. Sutherland, and R.I. Richards Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat Cell 88 1997 367 374
28. A. Latil, O. Cussenot, G. Fournier, K. Driouch, and R. Lidereau Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions Cancer Res. 57 1997 1058 1062
29. A.M. Oliveira, B.L. Hsi, S. Weremowicz, A.E. Rosenberg, P. Dal Cin, N. Joseph, J.A. Bridge, A.R. Perez-Atayde, and J.A. Fletcher USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst Cancer Res. 64 2004 1920 1923
30. K. Tobal, P.R. Johnson, M.J. Saunders, C.J. Harrison, and J.A. Liu Yin Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission Br. J. Haematol. 91 1995 104 108
31. S. Li, R.J. Couzi, G.H. Thomas, A.D. Friedman, and M.J. Borowitz A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy Cancer Genet. Cytogenet. 125 2001 74 77
32. C.M. Vajdic, A.M. Hutchins, A. Kricker, J.F. Aitken, B.K. Armstrong, N.K. Hayward, and J.E. Armes Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study Cancer Genet. Cytogenet. 144 2003 12 17
33. R.N. Wiltshire, T.R. Dennis, V.K. Sondak, P.S. Meltzer, and J.M. Trent Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma Cancer Genet. Cytogenet. 131 2001 97 103
34. M. Karadag, B. Tunca, G. Cecener, U. Egeli, N. Ozyardimci, E. Ege, and O. Gozu Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer Teratog., Carcinog., Mutagen. 22 2002 31 40
35. D.I. Smith, H. Huang, and L. Wang Common fragile sites and cancer (review) Int. J. Oncol. 12 1998 187 196
36. T.W. Glover, and C.K. Stein Chromosome breakage and recombination at fragile sites Am. J. Hum. Genet. 43 1988 265 273
37. I. Osman, H. Scher, G. Dalbagni, V. Reuter, Z.F. Zhang, and C. Cordon-Cardo Chromosome 16 in primary prostate cancer: a microsatellite analysis Int. J. Cancer 71 1997 580 584
38. T. Ahrens, J.P. Sleeman, C.M. Schempp, N. Howells, M. Hofmann, H. Ponta, P. Herrlich, and J.C. Simon Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid Oncogene 20 2001 3399 3408
39. J.H. Jang Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells Biochem. Biophys. Res. Commun. 292 2002 378 382
40. B. Nawrocki-Raby, C. Gilles, M. Polette, E. Bruyneel, J.Y. Laronze, N. Bonnet, J.M. Foidart, M. Mareel, and P. Birembaut Upregulation of MMPs by soluble E-cadherin in human lung tumor cells Int. J. Cancer 105 2003 790 795
41. 2+-dependent cell-cell adhesion molecule homologous to mouse placental cadherin: its low expression in human placental tissues J. Cell Biol. 109 1989 1787 1794